|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
DEGRUYTEROA_on1260162501 |
003 |
OCoLC |
005 |
20240209213017.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
210302s2021 enk ob 001 0 eng |
040 |
|
|
|a NLM
|b eng
|e rda
|c NLM
|d N$T
|d VT2
|d UKMGB
|d YDX
|d OCLCO
|d GUA
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCL
|d OCLCO
|d OCLCA
|d UUM
|d OCLCL
|d OCLCA
|d OCLCL
|
015 |
|
|
|a GBC0H4046
|2 bnb
|
016 |
7 |
|
|a 101776778
|2 DNLM
|
016 |
7 |
|
|a 020001367
|2 Uk
|
019 |
|
|
|a 1258398985
|
020 |
|
|
|z 9781526141026
|q (hardback)
|
020 |
|
|
|a 9781526141019
|q (web)
|
020 |
|
|
|a 1526141019
|
020 |
|
|
|a 9781526156532
|q (ePub)
|
020 |
|
|
|a 1526156539
|
020 |
|
|
|z 1526141027
|
029 |
1 |
|
|a UKMGB
|b 020001367
|
029 |
1 |
|
|a AU@
|b 000069446804
|
029 |
0 |
|
|a NLM
|b 101776778
|
029 |
1 |
|
|a AU@
|b 000070135787
|
029 |
1 |
|
|a AU@
|b 000069696789
|
035 |
|
|
|a (OCoLC)1260162501
|z (OCoLC)1258398985
|
037 |
|
|
|a ManchesterUniversityPress13936
|b Ingram Content Group
|
042 |
|
|
|a pcc
|
043 |
|
|
|a e-uk---
|
050 |
|
4 |
|a RC271.G45
|b K477 2021eb
|
060 |
0 |
0 |
|a QZ 266
|
082 |
0 |
4 |
|a 616.99/40695
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Kerr, Anne,
|d 1969-
|e author.
|1 https://id.oclc.org/worldcat/entity/E39PCjGqxc7QqMqyxpXbWBXgYX
|
245 |
1 |
0 |
|a Personalised cancer medicine :
|b future crafting in the genomic era /
|c Anne Kerr, Choon Key Chekar, Emily Ross, Julia Swallow, Sarah Cunningham-Burley.
|
264 |
|
1 |
|a Manchester :
|b Manchester University Press,
|c 2021.
|
300 |
|
|
|a 1 online resource (1 PDF file (viii, 277 pages)).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Inscriptions
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
3 |
|
|a What does it mean to personalise cancer medicine? Drawing on an ethnographic study with cancer patients, carers and practitioners in the UK, this book traces their efforts to access and interpret novel genomic tests, information and treatments as they craft personal and collective futures. Exploring multiple experiences of new diagnostic tests, research programmes and trials, advocacy and experimental therapies, the authors chart the different kinds of care and work involved in efforts to personalise cancer medicine, as well as the ways in which benefits and opportunities are unevenly realised and distributed. Comparing these experiences with policy and professional accounts of the 'big' future of personalised healthcare, the authors show how hope and care are multi-faceted, contingent and, at times, frustrated in the everyday complexities of living and working with cancer.
|
588 |
|
|
|a Description based on online resource; title from PDF title page (viewed October 22, 2021).
|
506 |
0 |
|
|a Open Access
|5 EbpS
|
505 |
0 |
0 |
|t Front matter --
|t Contents --
|t Acknowledgements --
|t Introduction --
|t 1 Personalising cancer treatment and diagnosis through genomic medicine --
|t 2 Genomic techniques in standard care --
|t 3 Molecular profiling for advanced gynaecological cancer --
|t 4 Optimising personalisation --
|t 5 Genomics at scale --
|t 6 Going private --
|t 7 At the limits of participation --
|t Conclusion --
|t Bibliography --
|t Index
|
590 |
|
|
|a De Gruyter Online
|b De Gruyter Open Access eBooks
|
650 |
|
0 |
|a Cancer
|x Gene therapy
|x Social aspects
|z Great Britain.
|
650 |
|
0 |
|a Cancer
|x Treatment
|z Great Britain.
|
650 |
|
0 |
|a Genomics
|z Great Britain.
|
650 |
|
0 |
|a Precision medicine
|z Great Britain.
|
650 |
|
0 |
|a Precision medicine.
|
650 |
1 |
2 |
|a Neoplasms
|x therapy
|
650 |
1 |
2 |
|a Precision Medicine.
|
650 |
|
6 |
|a Cancer
|x Thérapie génique
|x Aspect social
|z Grande-Bretagne.
|
650 |
|
6 |
|a Cancer
|x Traitement
|z Grande-Bretagne.
|
650 |
|
6 |
|a Génomique
|z Grande-Bretagne.
|
650 |
|
6 |
|a Médecine de précision
|z Grande-Bretagne.
|
650 |
|
6 |
|a Médecine de précision.
|
650 |
|
7 |
|a Cancer
|x Treatment
|2 fast
|
650 |
|
7 |
|a Genomics
|2 fast
|
650 |
|
7 |
|a Precision medicine
|2 fast
|
651 |
|
7 |
|a Great Britain
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJdmp7p3cx8hpmJ8HvmTpP
|
653 |
|
|
|a cancer.
|
653 |
|
|
|a care.
|
653 |
|
|
|a futures.
|
653 |
|
|
|a genomics.
|
653 |
|
|
|a oncology.
|
653 |
|
|
|a participation.
|
653 |
|
|
|a patients.
|
653 |
|
|
|a personalised medicine.
|
653 |
|
|
|a precision medicine.
|
653 |
|
|
|a technoscience.
|
700 |
1 |
|
|a Chekar, Choon Key,
|e author.
|
700 |
1 |
|
|a Ross, Emily
|c (Medical sociologist),
|e author.
|1 https://id.oclc.org/worldcat/entity/E39PCjFvCwmrfMY7HXxWgQqQhd
|
700 |
1 |
|
|a Swallow, Julia Elizabeth,
|e author.
|
700 |
1 |
|
|a Cunningham-Burley, Sarah,
|e author.
|
758 |
|
|
|i has work:
|a Personalised cancer medicine (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGgC43dCfCCWQbXwr7CtgC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Kerr, Anne, 1969-
|t Personalised cancer medicine.
|d Manchester Manchester University Press 2021
|z 9781526141026
|w (OCoLC)1153475414
|
830 |
|
0 |
|a Inscriptions (Manchester University Press)
|
856 |
4 |
0 |
|u https://www.degruyter.com/openurl?genre=book&isbn=9781526141019
|z Texto completo
|
938 |
|
|
|a De Gruyter
|b DEGR
|n 9781526141019
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 2959718
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 302504890
|
994 |
|
|
|a 92
|b IZTAP
|